selected publications
-
academic article
- CLytA-DAAO, Free and Immobilized in Magnetic Nanoparticles, Induces Cell Death in Human Cancer Cells. BIOMOLECULES. 222-240. 2020
- Cell death Mechanisms induced by CLytA-DAAO chimeric enzyme in human tumor cell lines. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 8522-8546. 2020
- Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines. CANCERS. 1-18. 2020
- Grupo de Innovación Docente en el Grado de Biotecnología. SEM@FORO . 32-33. 2020
- HGUE-C-1 is an atypical and novel colon carcinoma cell line. BMC CANCER. 240-256. 2015
- Liver damage and caspase-dependent apoptosis is related to protein malnutrition in mice: effect of methionine.. ACTA HISTOCHEMICA. 126-135. 2015
- Comparative study of 17-AAG and NVP-AUY922 in pancreatic and colorectal cancer cells: Are there common determinants of sensitivity?. TRANSLATIONAL ONCOLOGY. 590-604. 2014
- Liver damage and caspase-dependent apoptosis is related to protein malnutrition in mice: effect of methionine. ACTA HISTOCHEMICA. 1-30. 2014
- Resistance to Selumetinib (AZD6244) en colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.. NEOPLASIA. 845-860. 2014
- Role of Receptor Tyrosine Kinases and Their Ligands in Glioblastoma. CELL. 199-235. 2014
- Acquisition of MDR Phenotype by Leukemic Cells Is Associated With Increased Caspase-3 Activity and a Collateral Sensitivity to Cold Stress. JOURNAL OF CELLULAR BIOCHEMISTRY. 1416-1425. 2012
- Dual regulation of P-glycoprotein expression by Trichostatin A in cancer cell lines. BMC MOLECULAR BIOLOGY. 25-34. 2012
- Dual regulation of P-glycoprotein expression by Trychostatin A in cancer cell lines. BMC MOLECULAR BIOLOGY. 25-47. 2012
- ACQUISITION OF MDR PHENOTYPE BY LEUKEMIC CELLS IS. JOURNAL OF CELLULAR BIOCHEMISTRY. 2011
- Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level. CANCER LETTERS. 192-203. 2010
- Serine proteases in histone deacetylase inhibitor-induced apoptosis still an unresolved question. MOLECULAR CANCER THERAPEUTICS. 2441-2443. 2010
- Tumour cells resistance in cancer therapy.. CLINICAL & TRANSLATIONAL ONCOLOGY. 13-20. 2007
- Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G2/M arrest in glioblastoma cell lines. ONCOGENE. 7185-7193. 2007
- Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines. . MOLECULAR CANCER RESEARCH. 641-653. 2007
- Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells. . INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 1877-1885. 2007
- Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells. MOLECULAR CANCER THERAPEUTICS. 2172-2181. 2006
- Inhibition of Hsp90 function causes dowregulation of cdc2 and cdc25C and G2/M arrest in glioblastoma cell lines. . ONCOGENE. 2006
- Molecular biology of exocrine pancreatic cancer. CLINICAL & TRANSLATIONAL ONCOLOGY. 306-312. 2006
- Molecular mechanisms of tumour cell resistance. CLINICAL & TRANSLATIONAL ONCOLOGY. 13-20. 2006
- Differential regulation of cyclin D3 by rapamycin in HER2 overexpressing breast cancer cells. MOLECULAR CANCER THERAPEUTICS. 2005
- Differentiation and drug resístanse relationships in leukemia cells. JOURNAL OF CELLULAR BIOCHEMISTRY. 98-108. 2005
- Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines.. MOLECULAR CANCER THERAPEUTICS. 1222-1230. 2005
- P53 regulation of estrogen receptor-á expression in MCF-7 cells. JOURNAL OF ENDOCRINOLOGY. 497-504. 2004
- Taxol regulation of estrogen receptor-á expression in MCF-7 cells. JOURNAL OF ENDOCRINOLOGY. 487-496. 2004
- Suscetibility of multidrug resistance tumor cells to apoptosis induction by histone deacetilase inhibitors. INTERNATIONAL JOURNAL OF CANCER. 579-586. 2003
- Trichostatin A effects in different drug-resistant tumor cell lines. ACTA DIABETOLOGICA. 175-179. 2002
- Trichostatin A effects in different drug-resistant tumor cell lines.. ACTA DIABETOLOGICA. 175-179. 2002
-
chapter
- Evaluation of the degree of student satisfaction. VI Simposio Internacional de Innovación Aplicada. 42-43. 2019
- Implementation of new teaching innovation tools in the biotechnology degree from the UMH: Evaluation of the degree of impact on academic perfomance. VI Simposio Internacional de Innovación Aplicada. 48-49. 2019
- Abordaje multidisciplinar sanitario de un paciente oncológico desde distintos puntos de vista: genético, farmacológico y funcional.. Monografico innovacion UMH 2017. 2-8. 2018
- Cell Death and Cancer. Novel Therapeutic Strategies. apoptosis and medicine. 67-110. 2012
- Immunoliposomes: A Multipurpose Strategy in Breast Cancer Targeted Therapy. Breast Cancer - Current and Alternative Therapeutic Modalities . 1-18. 2011
-
congress communication
- Implementación de nuevas herramientas de innovación docente en el Grado de Biotecnología de la UMH: Evaluación del grado de satisfacción del alumnado. 2019
- Implementación de nuevas herramientas de innovación docente en el Grado de Biotecnología de la UMH: Evaluación del impacto en el rendimiento académico 2019
- Twitter en las aulas de biotecnología. Ahora es el turno de los alumnos 2018
- La inhibición de PTK6 potencia los efectos del anticuerpo anti EGFR cetuximab y de los inhibidores de la actividad tirosin kinasas del receptor sobre la proliferación de células tumorales pancreáticas. 2017
- Aplicación de las técnicas de acoplamiento molecular al desarrollo de nuevos fármacos antitumorales 2016
- Implicación de los genes SOCS 1 y SOCS 3 en la resistencia a la radioterapia 2016
- Una terapia enzimática de base nanotecnologica induce muerte celular en líneas celulares de cáncer 2016
- Anti-EGFR therapy is potentiated by inhibiting PTK-6 in pancreatic carcinoma cell lines 2015
- D-aminoacid oxidase enzymatic therapy potentiates the effects of radiotherapy in glioblastoma primary cultures 2015
- D-aminoacid oxidase nanoparticles induced cell death in cancer cell lines 2015
- Differential effects of IGF-1R inhibitors BMS-754807 and OSI-906 in human cancer cell lines. 49-50. 2015
- Insights on histone deacetylase inhibitors ¿ induced cell death in cancer cell lines. 41-42. 2015
- Insights on histone deacetylase inhibitors-induced cell death in cancer cell lines 2015
- Nanotechnology based D-aminoacid oxidase enzymatic therapy potentiates the effects of radiotherapy in glioblastoma primary cultures.. 135-135. 2015
- PDGFR and IGF-1R inhibitors induce G2/M arrest and subsequent cell death in human glioblastoma cell lines and primary cultures. 50-50. 2015
- PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation. 16-17. 2015
- Radiotherapy gets improved by a nanothecnology-based enzyme therapy 2015
- Bioactive compounds of Rosmarinus officinalis against colon cancer cell lines and histopathological evaluation of oral acute toxicity in rats exposed to the extract 2014
- IN SILICO DESIGN OF NEW THERAPEUTIC MOLECULES AGAINST DIMERIZATION OF HUMAN IGFR-1 AND EGFR RECEPTORS 2014
- Differential effects of EGFR inhibitors in pancreatic carcinoma cell lines. 69-69. 2010
- HGUE-C-1 a novel colon carcinoma cell line. 197-198. 2010
- Overcoming chemorresistance in pancreatic and colorectal cell lines. 71-71. 2010
- Protein malnutrition activates caspase-independent apoptosis in mouse liver .Methionine protection. 65-65. 2010
- Study of the regulation of DUSP6 expression as a chemorresistance mechanisms in exocrine pancreatic cancer. 56-56. 2010
- Alteration of MAPK signalling pathways in multidrug resistant and P-GP-transfected leukaemic cell lines. 70-70. 2009
- Implication of P-glycoprotein on cold stress induced-cell-death in a leukemic cell line by a caspases-dependent mechanisms. 91-91. 2009
- Kinase inhibitors as therapeutical tools for colorectal cancer. 93-93. 2009
- Multidrug resistance and apoptosis in human leukaemic cell lines. 386-386. 2009
- Regulation of P-glycoprotein and multidrug resistance protein expression by histone deacetylase inhibitors in cancer cells. 62-62. 2009
- Relationship between apoptosis, cell differentiation and multidrug resistance in human leukaemic cells.. 104-104. 2009
- Targeting tyrosine kinase receptors in glioblastoma multiforme. 111-112. 2009
- Cold Stress induces apoptosis in a multidrug resistant leukaemic cell line by a caspases-dependent mechanism. 76-76. 2008
- Implication of MAPK signalling pathways on cold stress-induced apoptosis in a multidrug resistant leukaemic cell line. 144-144. 2008
- Insights into histone deacetylase inhibitors-induced apoptosis in cancer cell lines. 28-28. 2008
- La diferenciación celular modula la resistencia a apoptosis en lineas de leucemia humana 2008
- TSA regulates P-glycoprotein and multidrug resistance associated protein expression in cancer cells. 136-137. 2008
- Epidermal growth factor receptor inhibition reduces cell proliferation of glioblastoma multiforme cell lines. . 45-45. 2007
- La inhibición de rutas de transducción de señales como estrategia terapéutica en glioblastoma multiforme 2007
- Muerte celular programada inducida por los inhibidores de desacetilasas de histonas.¿Un mecanismo común, o múltiples mecanismos dependientes del modelo celular? 2007
- PARP-1 inhibitors potentiate the histone deacetylase inhibitors-induced apoptosis in tumour cell lines from different origin. 44-44. 2007
- PKC-alfa antagoniza el efecto apoptótico inducido por los inhibidores de las desacetilasas de histonas 2007
- Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines 2007
- Regulation of MDR1 gene expression, role of the histone deacetylase inhibitors. 24-24. 2007
- Study of the interaction between trichostatin and rapamycin in pancreatic-adenocarcinoma cell lines. 43-43. 2007
- Geldanamycin causes a G2/M arrest in glioblastoma cell lines 2006
- Insights on histone deacetylase inhibitors-induced apoptosis in hematopoietic cell lines 2006
- Insights on histone deacetylase inhibitors-induced apoptosis in pancreatic adenocarcinoma cell lines 2006
- Los inhibidores de PARP-1 potencian la apoptosis inducida por los inhibidores de las desacetilasas de histonas en diversas líneas celulares tumorales 2006
- Los inhibidores de las desacetilasas de histonas en el tratamiento del cáncer 2006
- The S1c1a1 gene polymorphism, (GT)n at the promoter region, and bladder cancer in spanish population 2006
- Desarrollo y evaluación de nuevos abordajes terapéuticos y de modelos de experimentación animal para el tratamiento del carcinoma de páncreas exocrino 2005
- Investigación traslacional en cáncer. Grupo de Oncología Molecular del Hospital general Universitario de Elche 2005
- La apoptosis inducida por los inhibidores de las desacetilasas de histonas es dependiente de la actividad de una o varias serín-proteasas en varios modelos celulares quimiorresistentes 2005
- Los inhibidores de PARP-1 potencian la apoptosis inducida por los inhibidores de desacetilasas de histonas en diversas líneas celulares tumorales 2005
- Los inhibidores de las desacetilasas de histonas (iHDACs) inducen apoptosis caspasa-independiente y serín proteasa-dependiente en líneas celulares de adenocarcinoma humano de páncreas exocrino 2005
- Regulación de la ciclina D3 por la rapamicina en células que sobreexpresan HER2 2005
- Regulación postranscripcional de glicoproteína P en líneas celulares de carcinoma humano de colon 2005
- Targeting expresión of estrogen receptor a for therapy 2005
- Análisis of TGFBR1 gene in colorectal carcinoma 2004
- ER alfa, SRC y hormonoindependencia 2004
- La activación de PKC alfa en lineas celulares hematopoyeticas las protege de la inducción de apoptosis por inhibidores de las desacetilasas de histonas 2004
- La inducción de apoptosis en líneas celulares de carcinoma de páncreas exocrino por los inhibidores de las deacetilasas de histonas es independiente de la activación de las caspasas 2004
- Mecanismos de apoptosis inducidos por tricostatina A en líneas celulares de leucemia murina y humana 2004
- Mecanismos de inducción de apoptosis en líneas celulares de adenocarcinoma de páncreas por inhibidores de las desacetilasas de histonas 2004
- Mecanismos de inducción de apoptosis por los inhibidores de las deacetilasas de histonas en líneas celulares de leucemia murina y humana 2004
- : Post-transcriptional regulation of P-glycoprotein expresión in human colon carcinoma cell lines 2003
- Efectos de la tricostatina A en la expresión de MSH6, MSH2, MLH1 y MGMT en líneas celulares de carcinomas humanos 2003
- Efectos de la tricostatina A en la expresión de MSH6, MSH2, MLH1 y MGMT en líneas celulares de carcinomas humanos 2003
- Inducción de apoptosis mediada por los inhibidores de las desacetilasas de histonas en líneas celulares de carcinoma pancreático humano 2003
- Papel de las PKC clásicas en la resistencia a los inhibidores de las desacetilasas de histonas en la línea celular de leucemia múrina L1210 2003
- Post-transcriptional regulation of P-glycoprotein expression in human colon carcinoma cell lines 2003
- Post-transcriptional regulation of P-glycoprotein expression in human colon carcinoma cell lines 2003
- Regulación postranscripcional del gen MDR1 en líneas celulares de carcinoma de colon: Implicaciones en el análisis de la quimiorresistencia de las células tumorales 2003
- Regulación postranscripcional del gen MDR1 en líneas celulares de carcinoma de colon: implicaciones en el análisis de la quimiorresistencia de las células tumorales. 2003
- Different signal transduction pathways interfere with histone deacetylase inhibitors induced apoptosis in murine leukemia cells bearing MDR phenotype 2002
- Inducción de apoptosis por inhibidores de las desacetilasas de histonas en líneas celulares de carcinoma de páncreas humano 2002
- P-glycoprotein regulation by histone deacetylase inhibitors in tumor cell bearing multiple drug resistance phenotype (MDR) 2002
- P-glycoprotein regulation by histone deacetylase inhibitors in tumor cell bearing multiple drugs resistance phenotype (MDR) 2002
- Regulation of P-glycoprotein expression and activity in cancer cells: Identification of a possible translational mechanism 2002
- Regulation of P-glycoprotein expression and activity in cancer cells: Identification of a possible translational mechanism 2002
- Selective apoptosis induction by histone deacetylase inhibitors in tumor cell bearing a Multidrug- resistance phenotype (MDR) 2002
- Selective apoptosis induction by histone deacetylase inhibitors in tumor cell bearing a multidrug-resistant phenotype (MDR) 2002
- Diferenciación celular y quimiorresistencia en cancer de colon 2001
- Identificación a partir de quimotecas combinatorias de nuevos reversores del fenotipo MDR 2000
- Efecto de la Tricostatina-A en células de leucemia murina y relación con el fenómeno MDR 1999
- Fenotipo de resistencia a múltiples fármacos y maduración celular inducida en una línea de leucemia mieloide humana 1999
- Regulación del gen del receptor de estrógenos tipo alfa por p53 en células MCF-7 1999